Non-Small Cell Lung Cancer Therapeutics Market to Reach US $43,713.1 Mn, Growing Adoption of Targeted Therapy for Diagnosis to Boost the Market
The Global Non-Small Cell Lung Cancer Therapeutics Market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to a report published by Fortune Business Insights, titled 'Non-Small Cell Lung Cancer Therapeutics: Global Market Analysis, Insights and Forecasts, 2019-2026,' the market value will rise substantially from US$ 16,011.7 Mn in 2018 to US$ 43,713.1 Mn by 2026.
View full press release